Antje Neumann

1.7k total citations
27 papers, 1.4k citations indexed

About

Antje Neumann is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Antje Neumann has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Antje Neumann's work include Immunotherapy and Immune Responses (11 papers), vaccines and immunoinformatics approaches (5 papers) and T-cell and B-cell Immunology (4 papers). Antje Neumann is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), vaccines and immunoinformatics approaches (5 papers) and T-cell and B-cell Immunology (4 papers). Antje Neumann collaborates with scholars based in Germany, United States and Switzerland. Antje Neumann's co-authors include Elke Jäger, Julia Karbach, Alexander Knuth, Lloyd J. Old, Sacha Gnjatic, Gerd Ritter, Akin Atmaca, Eric W. Hoffman, Dirk Jäger and Armin Bender and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Antje Neumann

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antje Neumann Germany 15 933 638 603 109 104 27 1.4k
Sarah L. Buchan United Kingdom 18 829 0.9× 392 0.6× 434 0.7× 81 0.7× 102 1.0× 26 1.1k
Aleksandar Dakic Australia 14 1.2k 1.2× 871 1.4× 667 1.1× 43 0.4× 104 1.0× 18 2.2k
Stanley Chaleff United States 7 679 0.7× 437 0.7× 468 0.8× 50 0.5× 247 2.4× 8 1.5k
Jan Diekmann Germany 10 1.4k 1.5× 717 1.1× 1.1k 1.8× 177 1.6× 131 1.3× 12 1.8k
Guang Huan Tu United States 9 520 0.6× 541 0.8× 599 1.0× 130 1.2× 278 2.7× 11 1.2k
Marie King Ireland 6 711 0.8× 437 0.7× 459 0.8× 51 0.5× 317 3.0× 13 1.6k
Annechien J.A. Lambeck Netherlands 18 926 1.0× 341 0.5× 428 0.7× 47 0.4× 102 1.0× 27 1.2k
Xue F. Huang United States 20 781 0.8× 710 1.1× 587 1.0× 47 0.4× 289 2.8× 34 1.6k
Shawn M. Jensen United States 19 784 0.8× 295 0.5× 882 1.5× 75 0.7× 117 1.1× 37 1.4k
Monica Moro Italy 21 884 0.9× 491 0.8× 292 0.5× 94 0.9× 96 0.9× 29 1.5k

Countries citing papers authored by Antje Neumann

Since Specialization
Citations

This map shows the geographic impact of Antje Neumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Neumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Neumann more than expected).

Fields of papers citing papers by Antje Neumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Neumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Neumann. The network helps show where Antje Neumann may publish in the future.

Co-authorship network of co-authors of Antje Neumann

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Neumann. A scholar is included among the top collaborators of Antje Neumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Neumann. Antje Neumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Neumann, Antje. (2019). Wilderness Protection in Polar Regions. 1 indexed citations
3.
Karbach, Julia, Antje Neumann, Kathrin Brand, et al.. (2012). Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity. Clinical Cancer Research. 18(19). 5449–5459. 79 indexed citations
4.
Karbach, Julia, Antje Neumann, Claudia Wahle, et al.. (2012). Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies. Cancer Research. 72(17). 4304–4310. 18 indexed citations
5.
Weidmann, Eckhart, Antje Neumann, F. Fauth, et al.. (2011). Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas. Annals of Oncology. 22(8). 1839–1844. 65 indexed citations
6.
Neumann, Antje, et al.. (2011). Wingless ant males adjust mate-guarding behaviour to the competitive situation in the nest. Animal Behaviour. 82(2). 339–346. 16 indexed citations
7.
Karbach, Julia, Antje Neumann, Akin Atmaca, et al.. (2010). Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients. Clinical Cancer Research. 17(4). 861–870. 63 indexed citations
8.
Neumann, Antje, Julia Karbach, Akin Atmaca, & Elke Jäger. (2010). Langzeitremission bei malignem Melanom Stadium IV nach antigenspezifischer Immuntherapie. Medizinische Klinik. 105(4). 273–275.
9.
Karbach, Julia, Sacha Gnjatic, Armin Bender, et al.. (2009). Tumor‐reactive CD8+ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival. International Journal of Cancer. 126(4). 909–918. 100 indexed citations
10.
Atmaca, Akin, Salah‐Eddin Al‐Batran, Antje Neumann, et al.. (2008). Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer — A phase II study. Gynecologic Oncology. 112(2). 384–388. 20 indexed citations
11.
Atmaca, Akin, S-E. Al-Batran, Alexander Maurer, et al.. (2007). Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial. British Journal of Cancer. 97(2). 177–182. 160 indexed citations
12.
Al‐Batran, Salah‐Eddin, A. Kerber, Akin Atmaca, et al.. (2007). Mitomycin C, 5-Fluorouracil, Leucovorin, and Oxaliplatin as a Salvage Therapy for Patients with Cisplatin-Resistant Advanced Gastric Cancer: A Phase I Dose Escalation Trial. Oncology Research and Treatment. 30(1-2). 29–34. 10 indexed citations
13.
Al‐Batran, Salah‐Eddin, Akin Atmaca, Antje Neumann, et al.. (2005). Intratumoral T-Cell Infiltrates and MHC Class I Expression in Patients with Stage IV Melanoma. Cancer Research. 65(9). 3937–3941. 53 indexed citations
14.
Al-Batran, Salah-Eddin, Akin Atmaca, D.H.J. Jager, et al.. (2004). Dose Escalation Study for Defining the Maximum Tolerated Dose of Continuous Oral Trofosfamide in Pretreated Patients with Metastatic Lung Cancer. Oncology Research and Treatment. 27(6). 534–538. 3 indexed citations
15.
Al-Batran, S-E., Antje Neumann, Akin Atmaca, et al.. (2004). LUD01–014: Phase 1/2 study of chimeric monoclonal antibody cG250 in combination with vinblastine in patients with advanced renal cell carcinoma (ARCC). Journal of Clinical Oncology. 22(14_suppl). 2531–2531. 2 indexed citations
16.
Atmaca, Akin, Alexander Maurer, Thorsten Heinzel, et al.. (2004). A dose-escalating phase I study with valproic acid (VPA) in patients (pts) with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 3169–3169. 3 indexed citations
17.
Westermann, Anneke M., G. Wiedemann, Elke Jäger, et al.. (2003). A Systemic Hyperthermia Oncologic Working Group Trial. Oncology. 64(4). 312–321. 23 indexed citations
18.
Jäger, Elke, Sacha Gnjatic, Yasuhiro Nagata, et al.. (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proceedings of the National Academy of Sciences. 97(22). 12198–12203. 363 indexed citations
19.
Neumann, Antje. (1987). [Dysmorphophobia. A report of experiences from the surgical special consultation].. PubMed. 19(3). 134–5. 1 indexed citations
20.
Neumann, Antje, et al.. (1972). [Septicemia caused by Pasteurella multocida in postnecrotic liver cirrhosis].. PubMed. 27(49). 2341–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah L. Buchan Breakdown of academic impact, for papers by Aleksandar Dakic Breakdown of academic impact, for papers by Stanley Chaleff Breakdown of academic impact, for papers by Jan Diekmann Breakdown of academic impact, for papers by Guang Huan Tu Breakdown of academic impact, for papers by Marie King Breakdown of academic impact, for papers by Annechien J.A. Lambeck Breakdown of academic impact, for papers by Xue F. Huang Breakdown of academic impact, for papers by Shawn M. Jensen Breakdown of academic impact, for papers by Monica Moro
Rankless by CCL
2026